Published in PLoS One on February 09, 2016
Placement of a Newly Designed Y-Configured Bilateral Self-Expanding Metallic Stent for Hilar Biliary Obstruction: A Pilot Study. Dig Dis Sci (2016) 0.83
Y-configured metallic stent combined with (125)I seed strands cavity brachytherapy for a patient with type IV Klatskin tumor. J Contemp Brachytherapy (2016) 0.75
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials (2007) 14.51
A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut (2004) 3.35
Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc (2010) 2.67
No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol (2012) 2.49
Endoscopic removal of malfunctioning biliary self-expandable metallic stents. Gastrointest Endosc (2005) 2.41
A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc (2010) 2.38
Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc (2006) 2.11
Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc (2011) 2.09
Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc (2003) 2.07
Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol (2007) 1.96
A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc (2006) 1.90
Removal of self-expandable metallic Wallstents. Gastrointest Endosc (2004) 1.88
Endoscopic removal of biliary self-expandable metallic stents: a prospective study. Endoscopy (2006) 1.83
Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. Am J Gastroenterol (2013) 1.76
No benefit of endoscopic sphincterotomy before biliary placement of self-expandable metal stents for unresectable pancreatic cancer. Clin Gastroenterol Hepatol (2015) 1.62
Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc (1988) 1.52
Comparison of the efficacy of covered versus uncovered metallic stents in treating inoperable malignant common bile duct obstruction: a randomized trial. J Vasc Interv Radiol (2014) 1.45
Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc (2002) 1.40
Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc (2005) 1.32
Endoscopic management of occluded biliary Wallstents: a cancer center experience. Gastrointest Endosc (2003) 1.24
Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. Gastrointest Endosc (2012) 1.14
Management of distal malignant biliary obstruction with the ComVi stent, a new covered metallic stent. Surg Endosc (2009) 1.11
Percutaneous treatment of malignant jaundice due to extrahepatic cholangiocarcinoma: covered Viabil stent versus uncovered Wallstents. Cardiovasc Intervent Radiol (2009) 1.09
Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer (JM-test): Covered Wallstent versus DoubleLayer stent. Dig Endosc (2011) 1.08
Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy (2006) 1.00
A prospective randomized study of hydrophilic polymer-coated polyurethane versus polyethylene stents in distal malignant biliary obstruction. Endoscopy (2003) 0.99
Pancreatic and biliary stents. Gastrointest Endosc (2013) 0.97
Percutaneous palliation of pancreatic head cancer: randomized comparison of ePTFE/FEP-covered versus uncovered nitinol biliary stents. Cardiovasc Intervent Radiol (2010) 0.97
Clinical experience with covered wallstents for biliary malignancies: 23-month follow-Up. Cardiovasc Intervent Radiol (1998) 0.96
Metallic stents and plastic endoprostheses in percutaneous treatment of biliary obstruction. Z Gastroenterol (2002) 0.88
Self-expanding metal stents versus polyethylene stents for palliative treatment in patients with advanced pancreatic cancer. Pancreas (2009) 0.86
A multicenter prospective study of the short-term outcome of a newly developed partially covered self-expandable metallic biliary stent (WallFlex(®)). Dig Dis Sci (2011) 0.85
Covered and uncovered self-expandable metallic Hanarostents are equally efficacious in the drainage of extrahepatic malignant strictures. Results of a double-blind randomized study. Scand J Gastroenterol (2013) 0.83
A new partially covered nitinol stent for palliative treatment of malignant bile duct obstruction: a multicenter single-arm prospective study. Endoscopy (2011) 0.83
A comparative analysis of PTFE-covered and uncovered stents for palliative treatment of malignant extrahepatic biliary obstruction. AJR Am J Roentgenol (2010) 0.83
Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion. Am J Gastroenterol (2001) 0.83
Recent advances of biliary stent management. Korean J Radiol (2012) 0.81
An Update to Hepatobiliary Stents. J Clin Transl Hepatol (2015) 0.77
The pro-resolving lipid mediator Maresin 1 protects against cerebral ischemia/reperfusion injury by attenuating the pro-inflammatory response. Biochem Biophys Res Commun (2016) 0.77
High Mobility Group Box 1 Mediates Interferon-γ-Induced Phenotypic Modulation of Vascular Smooth Muscle Cells. J Cell Biochem (2016) 0.75
Protein binding kinetics quantification via coupled plasmonic-photonic resonance nanosensors in generic microplate reader. Biosens Bioelectron (2019) 0.75